The University of Chicago Header Logo

Connection

Simon Hayward to Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Back to Details
This is a "connection" page, showing publications Simon Hayward has written about Leukemia, Myelogenous, Chronic, BCR-ABL Positive.
Simon Hayward
Connection Strength
0.555
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
  1. Tyrosine kinase inhibitor therapy prescribed for non-urologic diseases can modify PSA titers in urology patients. Prostate. 2019 02; 79(3):259-264.
    View in: PubMed
    Score: 0.555
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.